DIEBOLD NIXDORF, INC. v. ITC
para. 6 can only do so by presenting extrinsic evidence
that one of ordinary skill would fail to understand that a
term connotes a definite structure. Imposing such a
requirement would be inconsistent with the Supreme
Court’s guidance in Teva Pharmaceuticals, where the
Court held that, even in cases in which the district court
finds a need to look beyond the patent’s intrinsic evidence
and to consult extrinsic evidence, the district court must
still conduct a legal analysis: “whether a skilled artisan
would ascribe that same meaning to that term in the
context of the specific patent claim under review.” 135 S.
Ct. at 841. This is because “‘[e]xperts may be examined to
explain terms of art, and the state of the art, at any given
time,’ but they cannot be used to prove ‘the proper or legal
construction of any instrument of writing.’” Id. (alteration
in original) (quoting Winans v. N.Y. & Erie R. Co., 21
How. 88, 100–01 (1859)). In short, trial courts, after
deciding factual disputes, must interpret patent claims in
light of the facts that they found—“[t]his ultimate inter-
pretation is a legal conclusion,” and “appellate court[s]
can still review the [tribunal’s] ultimate construction of
the claim de novo.” Id. We specifically applied Teva’s
holding in the context of § 112, para. 6 in Skky, Inc. v.
MindGeek, s.a.r.l., 859 F.3d 1014 (Fed. Cir. 2017), ex-
plaining that “[t]he task of determining whether the
relevant claim language contains a means-plus-function
limitation is . . . a question of law that we review de novo.”
Id. at 1019 (alteration in original) (quoting TriMed, Inc. v.
Stryker Corp., 514 F.3d 1256, 1259 (Fed. Cir. 2008)).
Thus, in appropriate cases, a party advocating that a
claim limitation that does not recite the word “means” is
subject to § 112, para. 6 can overcome the presumption
against its application solely by reference to evidence
intrinsic to the patent. Diebold’s failure to contradict Dr.
Howard’s testimony with extrinsic evidence is not fatal to
its ability to overcome the presumption, as the Commis-
sion and Hyosung argue, unless we conclude that Dr.